Delivery Order SPE2DB22D3301-SPE2DB25FY4RB
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order with a Firm Fixed Price, is for the supply of XIFAXAN 550 mg tablets and has a ceiling value of $10,048.20. The contract has an ultimate completion date of January 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XIFAXAN 550 MG TABLET 60S. The Firm Fixed Price delivery order has a ceiling value of $106,634.16 and an ultimate completion date of September 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of XIFAXAN 550 mg tablets. The contract has a ceiling value of $2,087.82 and runs through January 15, 2025. It is a firm-fixed price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a firm fixed price of $1,213.74 and a completion date of June 3, 2024. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product XIFAXAN 550 mg tablets, with a ceiling value of $2,906.46 and a period of performance through April 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $11,806.49, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This $157,381.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,393.18 firm fixed-price delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,379.84, is a Delivery Order for the supply of XIFAXAN 550 mg tablets. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XIFAXAN 550 mg tablets over a period ending on September 23, 2024. The $40,062.50 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...